Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis

Iranian Journal of Kidney Diseases

Volumn 5, Issue 6, 2011, Pages 404-409

  Dashti Khavidaki, Simin ^a   Chamani, Nastaran ^a   Khalili, Hossein ^a   Talasaz, Azita Hajhossein ^a   Ahmadi, Farokhlegha ^b   Lessan Pezeshki, Mahboob ^b   Ghaeli, Padideh ^a   Dalili, Shirin ^c   Alimadadi, Abbas ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clonazepam; Hemodialysis; Sleep disorders; Zolpidem

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHATE BINDING AGENT; VITAMIN D; ZOLPIDEM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IRAN; MAINTENANCE THERAPY; MALE; PHASE 2 CLINICAL TRIAL; PITTSBURGH SLEEP QUALITY INDEX; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME;

ADULT; AGED; CLONAZEPAM; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GABA MODULATORS; HUMANS; HYPNOTICS AND SEDATIVES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PYRIDINES; QUALITY OF LIFE; RENAL DIALYSIS; SLEEP; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 80755126649     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sabbatini M, Minale B, Crispo A, et al. Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant. 2002;17:852-56.
2. Walker S, Fine A, Kryger MH. Sleep complaints are common in a dialysis unit. Am J Kidney Dis. 1995;26:751-56.
3. Holley JL, Nespor S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis. 1992;19:156-61.
4. Stepanski E, Faber M, Zorick F, et al. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1995;6:192-97.
5. Hui DS, Wong TY, Ko FW, et al. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000;36:783-8.
6. De Vecchi A, Finazzi S, Padalino R, et al. Sleep disorders in peritoneal and haemodialysis patients as assessed by a self administered questionnaire. Int J Artif Organs. 2000;23:237-42.
7. Elder SJ, Pisoni RL, Akizawa T, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from dialysis outcome and practice patterns study (DOPPS). Nephrol Dial Transplant. 2008;23:998-1004.
8. Benz RL, Pressman MR, Hovick ET, et al. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis. 2000;35:1052-60.
9. Afshar R, Emany A, Saremi A, et al. Effects of Intradialytic Aerobic Training on Sleep Quality in Hemodialysis Patients. Iran J Kidney Dis. 2011;5:119-23.
10. Molnar MZ, Novak M, Mucsi I. Management of restless leg syndrome in patients on dialysis. Drugs. 2006;66:607-24.
11. Skerritt JH, Johnston GA. Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur J Pharmacol. 1983;89:193-8.
12. Greenblatt DJ, Miller LG, Shader RI. Clonazepam pharmacokinetics, brain uptake, and receptor interactions. J Clin Psychiatr. 1987;48 Suppl: 4-11.
13. Terzano MG, Rossi M, Palomba V, et al. New drugs for insomnia: comparative tolerability of zopiclone, olpidem, and zaleplon. Drug Saf. 2003;26:261-82.
14. Berry RB, Patel PB. Effect of zolpidem on the efficacy of continuous positive airway pressure as treatment for obstructive sleep apnea. Sleep. 2006;29:1052-56.
15. Quadri S, Darke C, Hudgel DW. Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med. 2009;5:122-9.
16. Grimaldi D, Provini F, Vetrugno R, et al. Idiopathic central sleep apnoea syndrome treated with zolpidem. Neurol Sci. 2008;29:355-57.
17. Buysse DJ, Reynolds CF, Monk YH, et al. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
18. Sabbatini M, Crispo A, Pisani A, et al. Zaleplon improves sleep quality in maintenance hemodialysis patients. Nephron Clin Pract. 2003;94:c99-103.
19. Yoshioka M, Ishii T, Fukunishi I. Sleep disturbance of end-stage renal disease. Jpn J Psychiatry Neurol. 1993;47:847-51.
20. Maczaj M. Pharmacological treatment of insomnia. Drugs. 1993;45:44-55.
21. Converse RL, Jacobsen TN, Toto RD, et al. Sympathetic over activity in patients with chronic renal failure. N Eng J Med. 1992;327:1912-8.
22. DeBenedittis G, Cigada M, Bianchi A, et al. Autonomic changes during hypnosis: a heart rate variability power spectrum analysis as a marker of sympatho-vagal balance. Int J Clin Exp Hypn. 1994;42:140-52.
23. Gul A, Aoun N, Trayner EM Jr. Why do patients sleep on dialysis. Semin Dial. 2006;19:152-7.